Endoscopic diagnosis and treatment of primary multiple noninvasive malignant neoplasms of the stomach: clinical case-Reference-Cited by-同舟云学术

Endoscopic diagnosis and treatment of primary multiple noninvasive malignant neoplasms of the stomach: clinical case

Published:2024-05-18 Issue:5 Volume: Page:100-104
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:ECG

Author:

Sukhin D. G.¹^ORCID,Pirogov S. S.¹^ORCID,Ryabtseva V. I.¹^ORCID,Kuprina I. V.²^ORCID,Yutsevich O. K.¹^ORCID,Perfiliev I. B.¹^ORCID,Minibaeva G. F.¹^ORCID,Vodoleev A. S.¹^ORCID,Telegina L. V.¹^ORCID,Kaprin A. D.¹^ORCID

Affiliation:

1. P.A. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of Russi

2. I.M. Sechenov University Clinical Hospital № 1 of the First Russian State Medical University

Abstract

This clinical case describes a rare combination of early stage cancer and sporadic neuroendocrine tumor in stomach. The patient 57 years old admitted to P. A. Hertsen Moscow Oncology Research Institute for diagnostics and treatment for the gastric adenoma. Upper GI endoscopy performed in P. A. Hertsen Institute, detected two tumors: a sporadic neuroendocrine tumor in the middle part of the body stomach and early cancer in the antrum. With NBI (Narrow-Band Imaging), signs of malignancy were found in both tumors. А plan for therapeutic and diagnostic endoscopic surgical interventions was implemented: two sequential endoscopic submucosal dissection (ESD). This treatment confirmed as radical, according to the results of the pathological examination.

Publisher

LLC Global Media Technology

Reference16 articles.

1. Gilligan C.J., Lawton G. P., Tang L. H., West A. B., Modlin I. M. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol. 1995 Mar;90(3):338-52. PMID: 7872269.

2. Manfredi S., Walter T., Baudin E. et al. Management of gastric neuro-endocrine tumours in a large French national cohort (GTE). Endocrine (Basingstoke). 2017 Jun 29;57(3):504-11. doi: 10.1007/s12020-017-1355-9.

3. Sok C., Ajay P. S., Vasileios Tsagkalidis., Kooby D. A., Shah M. M. Management of Gastric Neuroendocrine Tumors: A Review. Annals of Surgical Oncology. 2023 Dec 7;31(3):1509-18. doi: 10.1245/s10434-023-14712-9.

4. Nagtegaal I.D., Odze R. D., Klimstra D. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019 Nov 13;76(2):182. doi: 10.1111/his.13975.

5. Min B.H., Hong M., Lee J. H. et al. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. British Journal of Surgery. 2018 Jun 12;105(11):1480-6. doi: 10.1002/bjs.10901.